Philips has launched the latest version of its software for managing image-guided therapy for structural heart disease, EchoNavigator 4.0, at the EuroPCR 2022 congress in Paris.
The new version of EchoNavigator 4.0 offers better integration of echocardiography and angiography modalities to provide fused images for use during interventional cardiology procedures, according to the company. The software is sold as a package in rooms that combine the company's Epiq CVXi echo system and Azurion angiography room.
EchoNavigator 4.0 gives users greater control of live fusion imaging during interventional cardiology procedures via a touchscreen that provides the ability to fuse and annotate echocardiography and x-ray fluoroscopy images. Anatomical features can be identified either manually or automatically, and anatomical markers and annotations that are applied to one modality are automatically transposed to the other.
What's more, live fusion images and markers, as well as annotations, are immediately visible to interventional cardiologists via a monitor on the Azurion system to guide deployment of catheterization and therapy devices. Also, the new version offers new anatomical modeling and transseptal puncture guidance during minimally invasive procedures, as well as new 3D live image fusion capabilities.
Finally, EchoNavigator 4.0 features automatic selection of an appropriate set of multiplanar reconstruction planes with presets for common views of the aortic and mitral valves and left atrial appendage.
EchoNavigator 4.0 is not yet available in all markets, including the U.S. and China.
